Subcutaneous Furosemide in Heart Failure

by Domenic A. Sica, MD, Pieter Muntendam, MD, Rene L. Myers, PhD, Jozine M. ter Maaten, MD, PhD, Mark E. Sale, MD, Rudolf A. de Boer, MD, PhD, Bertram Pitt, MD
Published 2018-02-01

Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients

by Lyanne M. Kieneker, MSc, Oliver Hartmann, MSc, Joachim Struck, PhD, Andreas Bergmann, PhD, Ron T. Gansevoort, MD, PhD, Michel M. Joosten, PhD, Else van den Berg, MD, PhD, Rudolf A. de Boer, MD, PhD, Stephan J.L. Bakker, MD, PhD
Published 2017-08-01

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

by Oriol Iborra-Egea, MSc, Evelyn Santiago-Vacas, MD, Salva R. Yurista, MD, Josep Lupón, MD, PhD, Milton Packer, MD, Stephane Heymans, MD, Faiez Zannad, MD, Javed Butler, MD, Domingo Pascual-Figal, MD, Antonio Lax, PhD, Julio Núñez, MD, PhD, Rudolf A. de Boer, MD, PhD, Antoni Bayés-Genís, MD, PhD
Published 2019-11-01